bannerImgipad bannerImgmob

Have You Been Diagnosed with Severe Aortic Stenosis?

You may be eligible for a research study that includes a minimally invasive option for aortic valve replacement.

Am I Eligible?

A New Aortic Valve Study for Patients

The purpose of the PARTNER 3 research study is to establish the safety and effectiveness of the transcatheter aortic valve replacement (TAVR) procedure for patients with severe aortic stenosis who are at low-risk for open surgical therapy. The study is sponsored by Edwards Lifesciences.

If you have been diagnosed with severe aortic stenosis, you may qualify for this study. Similar to many research studies, the PARTNER 3 study is a randomized study. This means that you have a 50/50 chance of receiving either surgical aortic valve replacement or TAVR. Regardless of which procedure you receive, the doctors and hospitals that participate in the study specialize in aortic stenosis therapy.

Start Patient Screener
60-second survey

This study is for patients experiencing severe aortic stenosis.

This study is for patients experiencing severe aortic stenosis.

doctorImg

How Do I Qualify for the TAVR Study?

Only the study doctor and/or research team can determine if you are eligible for this research study. You may be eligible if:

ageLimit

You have been diagnosed with severe aortic stenosis

heartbeat

You are not on home oxygen

med

You are not allergic to blood thinners like Coumadin

doctorImg

To learn if you are eligible for this research study, please call

(877) 826-7842, Monday through Friday, 9am to 5pm to learn more.

To learn if you are eligible for this research study, please call (877) 826-7842, Monday through Friday, 9am to 5pm to learn more.

Find Out If You Are Eligible

  • mobileImg

    Call (877) 826-7842

    Monday - Friday, 9am - 5pm

    Call Now
  • or

  • laptopImg

    Take the Online Screener

    60-Second Questionnaire

    Start Here